These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3906471)

  • 1. [Cytotoxic antibodies of HLA specificity after transplantation of the cornea].
    Gorgiladze TU; Shul'gina NS; Mitov TV
    Oftalmol Zh; 1985; (6):351-3. PubMed ID: 3906471
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of donor-reactive cytotoxic antibodies following cardiac transplantation.
    Smith JD; Morgan AJ; Bravery C; Rose ML; Sachs JA; Yacoub MH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1133-4. PubMed ID: 1989168
    [No Abstract]   [Full Text] [Related]  

  • 3. The association of cytotoxic antidonor HLA antibodies and mismatched marrow graft rejection.
    Ting A; Pun A; Atkinson K; Dodds A; Biggs J
    Transplant Proc; 1986 Apr; 18(2):264-6. PubMed ID: 3515662
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-HLA-A, B, C and DR antibodies in renal transplant recipients.
    Akiyama N; Kusaba R; Osawa N; Inou T; Kawamura A
    Jpn J Exp Med; 1980 Jun; 50(3):205-11. PubMed ID: 7001096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'Fc gamma RII blocking' (anti-TLX) alloantibody.
    Padányi A; Gyódi E; Rajczy K; Perner F; Petrányi GG
    Clin Transplant; 1996 Oct; 10(5):455-60. PubMed ID: 8930462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients.
    Zachary AA; Montgomery RA; Ratner LE; Samaniego-Picota M; Haas M; Kopchaliiska D; Leffell MS
    Transplantation; 2003 Nov; 76(10):1519-25. PubMed ID: 14657698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza virus-specific cytotoxic T lymphocytes recognize HLA-molecules. Blocking by monoclonal anti-HLA antibodies.
    McMichael AJ; Parham P; Brodsky FM; Pilch JR
    J Exp Med; 1980 Aug; 152(2 Pt 2):195s-203s. PubMed ID: 6967937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of flow cytometric crossmatching in cardiac transplantation.
    Shenton BK; Glenville BE; Mitcheson AE; Coates E; Talbot D; Givan AL; Kirk A; Dark JH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1153-4. PubMed ID: 1989175
    [No Abstract]   [Full Text] [Related]  

  • 10. Major histocompatibility complex or HL-A antibodies in patients with a rejection reaction [proceedings].
    van Dorp G; Völker-Dieben HJ; van Leeuwen A; Kok-Van Alphen CC; van Rood JJ
    Ophthalmologica; 1977; 175(1):42. PubMed ID: 333335
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-HLA antibodies after rejection of HLA identical kidney transplants.
    Zafar MN; Terasaki PI; Naqvi SA; Rizvi SA
    Clin Transpl; 2006; ():421-6. PubMed ID: 18365399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
    Hourmant M; Cesbron-Gautier A; Terasaki PI; Mizutani K; Moreau A; Meurette A; Dantal J; Giral M; Blancho G; Cantarovich D; Karam G; Follea G; Soulillou JP; Bignon JD
    J Am Soc Nephrol; 2005 Sep; 16(9):2804-12. PubMed ID: 16014742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of donor-recipient HLA disparity in the development of humoral immune reactions in corneal transplantation.
    Wagner E; Pagé B; Roy R; Langlois A; Boisjoly HM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):226-7. PubMed ID: 8438280
    [No Abstract]   [Full Text] [Related]  

  • 15. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
    Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of macrophage depletion on immune effector mechanisms during corneal allograft rejection in rats.
    Slegers TP; Torres PF; Broersma L; van Rooijen N; van Rij G; van der Gaag R
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2239-47. PubMed ID: 10892868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies.
    Glotz D; Antoine C; Julia P; Pegaz-Fiornet B; Duboust A; Boudjeltia S; Fraoui R; Combes M; Bariety J
    Transpl Int; 2004 Jan; 17(1):1-8. PubMed ID: 14685653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of antibodies to HLA antigens undetectable by the standard complement-dependent cytotoxicity test.
    Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vítko S; Valhová S; Stríz I; Ivasková E
    Transpl Int; 2003 Dec; 16(12):872-8. PubMed ID: 12904845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful renal transplantation in the presence of donor specific HLA IgM antibodies.
    Tardif GN; McCalmon RT
    Transplant Proc; 1995 Feb; 27(1):664-5. PubMed ID: 7879136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.